2021
DOI: 10.1016/j.jchromb.2021.122723
|View full text |Cite
|
Sign up to set email alerts
|

Optimization of a Screening Method for Macroprolactinemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 23 publications
0
5
0
Order By: Relevance
“…Macro-PRL consists of monomeric PRL complexed with immunoglobulins. Most macro-PRL (87%) is composed of monomeric PRL complexed with IgG ( 3 , 9 , 17 , 18 ). Within this category of PRL-IgG complexes, the majority (67%) involve anti-PRL autoantibodies ( Fig.…”
Section: Macroprolactin Structurementioning
confidence: 99%
See 4 more Smart Citations
“…Macro-PRL consists of monomeric PRL complexed with immunoglobulins. Most macro-PRL (87%) is composed of monomeric PRL complexed with IgG ( 3 , 9 , 17 , 18 ). Within this category of PRL-IgG complexes, the majority (67%) involve anti-PRL autoantibodies ( Fig.…”
Section: Macroprolactin Structurementioning
confidence: 99%
“…Therefore, it has been proposed that PRL autoantibodies present in patients with macroprolactinemia compete with PRL receptors for the binding of free PRL ( 9 ). Furthermore, macro-PRL is largely confined to the vascular space by its high MW and is unable to access target organs, such as the pituitary and hypothalamus ( 2 , 3 , 12 , 18 , 19 ). It is hypothesized that the low rates of oligomenorrhea and galactorrhea experienced by patients with macroprolactinemia are because of temporary dissociation of monomeric PRL from its immunoglobulin and hence a short-term increase in monomeric PRL ( 2 , 19 ).…”
Section: True Hyperprolactinemia and Macroprolactinemia Clinical Pres...mentioning
confidence: 99%
See 3 more Smart Citations